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Abstract
This book chapter aims to identify those bioactive compounds that are the most 
effective in obesity and hypertension prevention and/or treatment, these being 
the two main disorders associated with metabolic syndrome. Focusing on probiot-
ics and phytochemicals, the document will provide evidences from both in vitro 
and in vivo studies as well as information about the action mechanisms and how 
they are affected by the interaction with other food ingredients, the food matrix 
in which they are placed, etc. Given its high antioxidant capacity, in part due to its 
spermidine content, lulo fruit has generated considerable interest among health 
researchers. This, together with its exotic organoleptic properties, offers interesting 
growth opportunities for the design of new food products from lulo fruit. This book 
chapter will also discuss some of them.
Keywords: probiotics, phytochemicals, metabolic syndrome, spermidine, lulo
1. Foods, technology, and metabolic syndrome
Overweight and obesity are defined as “abnormal or excessive fat accumulation 
that may impair health” [1]. Since 1975, obesity has almost tripled worldwide so 
that in 2016, 39% of the adult population and 18% of children and adolescents were 
overweight. Very often, a high body mass index (BMI ≥ 25–30) is associated with 
other metabolic abnormalities, such as high blood pressure (hypertension), high 
blood sugar (hyperglycemia), high serum triglycerides, and low serum high-density 
lipoprotein (HDL) [2]. The occurrence of at least three of these interconnected 
physiological, biochemical, clinical, and metabolic factors that directly increase the 
risk of atherosclerotic cardiovascular disease, cancer, and type 2 diabetes is known 
as metabolic syndrome [3]. The International Diabetes Federation estimates that 
one-quarter of the world’s adult population suffers from this syndrome, with little 
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difference between developed and developing countries. Main factors contributing 
to it include, beyond the genetic susceptibility, the increased consumption of calo-
rie-dense food and the scarce physical activity. Given that metabolic syndrome can 
occur in several forms, according to the combination of the different components, it 
is apparently difficult to treat it pharmacologically, being lifestyle change the most 
effective preventive approach. However, the fact that a low-grade chronic inflam-
matory state accompanies the metabolic syndrome in any of its forms suggests that 
anti-inflammatory therapies could have a place in its prevention and treatment [4].
Inflammation is a response of the body’s immune system to harmful stimuli. In 
the case of metabolic syndrome, inflammation takes place in response to imbalance 
of blood glucose and insulin levels or insulin resistance, which leads to unhealthy 
high concentration of unused sugar in the bloodstream that is sent to the liver, 
muscle, or pancreas [5, 6]. Once there, the sugar is converted into fat, thus lead-
ing to progressive adipocyte enlargement. Hypertrophy reduces blood supply to 
adipocytes and causes hypoxia. Subsequent necrosis and macrophage infiltration 
into adipose tissue lead to overproduction of reactive oxygen species (ROS), 
low-density lipoproteins (LDLs), inflammatory cytokines (tumor necrosis factor-
alpha, interleukin-6, adiponectin, etc.), and C-reactive protein (CRP). High-fat 
diets, frequently consumed by obese individuals, aggravate this problem both 
directly, when the fat is rich in saturated fatty acids, and indirectly, through effects 
on the microbiota and intestinal permeability [5]. The normal blood plasma con-
centration of CRP varies between 0.08 and 0.3 mg/dL in healthy adults and reaches 
values between 2 and 10 mg/dL in individuals suffering from metabolic syndrome. 
High levels of the inflammatory marker CRP in blood are associated with increased 
odds of having plaque in the carotid arteries and, therefore, with increased risk of 
myocardial infarction and stroke [7].
In addition to CRP, some dietary food components involved as intermediates in 
various metabolic pathways appear altered in population with metabolic syndrome, 
making possible its use as biomarkers. Polyunsaturated fatty acids (PUFA), specifi-
cally eicosapentaenoic acid (20:5 n-3; EPA) and docosahexaenoic acid (22:6 n-3; 
DHA), are inversely related to metabolic syndrome in adults [8]; several studies have 
stablished an association between this syndrome and selenium blood concentration 
[9] or serum levels of vitamin B12 [10]; Urrunaga-Pastor et al. [11] also found an 
association between vitamin D deficiency and hyperinsulinemia; adults with meta-
bolic syndrome also have suboptimal concentrations of several antioxidants (retinyl 
esters, vitamin C, and all carotenoid concentrations, except lycopene), partly due 
to the lower intake of fruit and vegetables by these individuals [12]. These results 
reinforce the relationship between diet and the incidence of metabolic syndrome.
Evidence from prospective observational in vitro and in vivo studies (preclini-
cal and clinical trials) has converged to support the importance of individual 
nutrient or food intake and dietary patterns in the prevention and management of 
obesity and metabolic syndrome. In vitro studies seek to determine the biochemi-
cal mechanisms at the cellular level as physiological ones, which are involved in 
the proper functioning both at the transcriptional and protein expression in the 
pancreas, skeletal muscle, liver, and adipose tissue. In vivo studies allow establish-
ing a cause-effect relationship in experimental animals (preclinical trials) or in 
humans (clinical trials). While in vitro or animal in vivo studies are standardized 
and there are countless works done, even today a standard profile for clinical trials 
in humans with metabolic syndrome has not yet been established. Clinical trials 
about therapeutic efficacy for metabolic syndrome are scarce and concentrated in 
the last 8 years in high-income countries (USA, Italy, and Spain). Interventions that 
affect three or more factors and evaluate various outcome variables are reduced, 
highlighting the lifestyle factors (diet and physical activity) as the most important 
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in this multifactorial syndrome [13]. Specifically, a low intake of saturated and total 
fat; reduced consumption of sodium, simple sugars, and high glycemic index foods; 
and increased intake of fruits, vegetables, legumes, and whole grains are suggested 
to be the most effective actions in reducing the incidence of obesity and cardio-
vascular disease. However, the urban lifestyle leads us to mainly consume foods 
in processed form, which reinforces the decisive role that the food industry plays 
in the promotion of healthy diets. In fact, in recent years the supply of functional 
foods with a reduced content of fat, sugar or salt, as well as that of functional foods 
formulated with phytosterols or polyunsaturated fatty acids has increased consider-
ably. In order to achieve this, not only traditional techniques of food formulation 
and blending or cultivation and breeding are involved but also more recent ones, 
such as microencapsulation, vacuum impregnation, or coating with edible films 
[14]. Moreover, the increasing knowledge about the negative impact that process-
ing and cooking techniques have on the concentration and functionality of the 
active compounds naturally present in foods has encouraged the use of alternative 
techniques, such as the application of high-pressure homogenization replacing the 
pasteurization or freeze-drying instead of hot air drying.
Later in this book chapter, the most relevant bioactive compounds with proven 
effect against any disorder associated with the metabolic syndrome are listed. 
Focusing on probiotic microorganisms and phytochemical compounds, evidences 
obtained from in vitro, in vivo, or clinical studies in the last 10 years have been 
compiled. Finally, new functional foods made from lulo fruit are suggested as being 
suitable for metabolic syndrome prevention and/or amelioration.
2. Food components against metabolic syndrome
Main food components considered in the literature as having potential amelio-
rating effect on any disorder associated with metabolic syndrome may be included 
in one of the following groups:
• Fiber, both soluble (e.g., pectins, beta-glucans, naturally occurring gums, inu-
lin, psyllium) and insoluble (e.g., cellulose, hemicellulose, lignin), is reported 
to have laxative properties and to mitigate both hypercholesterolemia and 
hyperglycemia [15]. When fermented by probiotic bacteria, prebiotic fiber (fiber 
that resists digestion in the stomach and the small intestine and reaches the 
colon intact) breaks down into short-chain fatty acids (butyrate, acetate, and 
propionate), which are reported to enhance glucose and fat metabolism [16].
• Monounsaturated fats, polyunsaturated fats (both omega-3 and omega-6), plant 
sterols, and essential fatty acids instead of saturated fats and trans-fatty acids are 
proved to be effective in decreasing total cholesterol and increasing the blood 
level of high-density lipoproteins (HDLs) [17].
• Vitamin E and C consumption is associated to a reduction of vascular risk by 
decreasing oxidative stress (lipid peroxidation) and proinflammatory cyto-
kines [17]. Improved vitamin C status is hypothesized to alleviate endotoxemia 
and its consequent proinflammatory responses that are suggested to initiate 
insulin resistance and related metabolic disorders; on the contrary, inadequate 
vitamin C status contributes to small intestinal bacterial overgrowth, trans-
cytosis of enteric bacteria, and an elevation of circulating lipopolysaccharide, 
which elicits a low-grade inflammatory response [18]. As for vitamin D, it 
reduces the intestinal absorption of fat by increasing that of calcium [17].
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• Bioactive peptides, having a size range of 2–50 amino acids, have potential to 
regulate blood pressure and glycemia, reduce cholesterol level and body mass, 
and scavenge free radicals [19]. Lactotripeptides isoleucine-proline-proline 
and valine-proline-proline, whose concentrations increase during the ripening 
process of cheese, are particularly considered as strong antihypertensive agents 
[20]. In the case of obesity, foods that contain bioactive peptides provide a 
satiating effect and lead to appetite suppression.
• Minerals’ (selenium, magnesium, and zinc) ability to decline metabolic 
syndrome is related with their antioxidant properties and their participation 
in insulin synthesis and regulation [20]. Moreover, calcium intake (1200 mg/
day) has been demonstrated to increase fat mass loss in overweight and obese 
adults [21]. Mechanisms to explain this effect include that during low calcium 
intake, more calcium enters adipose tissues cells and subsequently stimulates 
the expression of lipogenic genes in parallel with suppressing lipolysis [22]. 
Also, calcium increases fecal fat loss by binding to fat in the lumen and forming 
non-absorbed complexes [23]. This ability of calcium to decrease lipogenesis 
may be enhanced due to a synergistic effect with other components in dairy 
products (vitamin D and angiotensin-converting enzyme inhibitors) [21].
• Essential amino acids, mainly histidine and glycine, are associated with a 
decrease in insulin resistance and blood pressure, respectively, although 
conclusive evidence is lacking and additional studies are needed [17].
• Phytochemicals, mainly polyphenols (phenolic acids, curcuminoids, stilbenes, 
lignans, flavonoids, flavonols, flavones, anthocyanins, etc.) but also other 
bioactive components present in small quantities in fruits and vegetables 
(triterpenes, carotenoids, etc.), have demonstrated anti-inflammatory, anti-
oxidative, antiadiposity, and cardioprotective functions in a huge amount of 
studies [24–28]. Some phytochemicals, among which are caffeine, ephedrine, 
capsaicin, and salicylic acid, also act as thermogenic compounds that produce 
heat from lipids and fats, thus burning extra calories and preventing the 
accumulation of fat in body tissues [20].
• Probiotics are microorganisms that improve the availability and digestibility of 
nutrients while maintaining the balance of intestinal microflora in the gut [20]. 
Mainly belonging to the Lactobacillus and Bifidobacterium genera, probiotics 
emerge as prospective biotherapies in the management of metabolic disorders 
including obesity and diabetes by counteracting the adverse effects of a high-
fat diet [29].
2.1 Phytochemicals
Phytochemicals are naturally occurring plant chemicals that, beyond providing 
plants with color, odor, and flavor, can influence chemical processes within human 
bodies in a beneficial way. Main phytochemicals under research include carotenoids 
(β-carotene, lycopene, lutein, zeaxanthin) and polyphenols, which include phenolic 
acids, flavonoids, and stilbenes/lignans [30]. Flavonoids can be further divided into 
groups based on their similar chemical structure, such as anthocyanins, flavones, 
flavanones, isoflavones, flavonols, and flavanols. Flavanols further are classified as 
catechins, epicatechins, and proanthocyanidins.
Phytochemical compounds have gained popularity in recent years due to their 
broadly documented effect in cancer prevention among other biological effects, 
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such as the prevention and treatment of obesity, cholesterol, and diabetes [31]. 
Mechanisms employed by phytochemicals in ameliorating metabolic syndrome risk 
factors are diverse and dependent on their particular chemical structure. Whereas 
catechins mainly induce fat oxidation and improve endothelial function, cyanidins 
and theaflavins inhibit enzymes involved in the synthesis of fatty acids and triglyc-
erides. Other phytochemicals, such as gallic acid, quercetin, and capsaicin, reduce 
preadipocyte proliferation by induction of cell apoptosis, while low-molecular 
proanthocyanidins have the ability to inhibit the activity of specific angiotensin-
converting enzyme. Having a similar chemical structure, isoflavones can also 
influence the activity of human estrogens.
For some bioactive components, several in vitro and in vivo (either animals or 
humans) studies have been performed; however, as evidenced in Tables 1–3, results 
differ among them. While in vitro or animal studies usually yield positive results, 
clinical human studies are still inconclusive. The lack of standardization or aspects 
related to the dose or duration of supplementation may be the cause of these results. 
Moreover, studies both in vitro and with animals (Tables 1 and 2) have been carried 
out with synthetic components (only spermidine was obtained directly from lulo 
fruit), while in vivo studies with humans have been carried out mainly with extracts 
including the bioactive compounds (Table 3).
Phytochemical(s) Methodology Beneficial effect(s) Reference
Synthesis naringenin 3T3-L1 cell line and Pemphigus 
vulgaris-treated HaCaT cell line.
Naringenin was added to the 
cell growing media in a dose 
of 25 μg/mL, and effect was 










acid, ursolic acid, 
celastrol, maslinic 
acid, ilexgenin A)
3 T3-L1 cell line or 10 T1/2 cells 
and primary fat SVF cells or 
HepG2 cells




lipolysis, and decreased 
adipocyte differentiation
[26]






ethanolic lulo pulp 
extract)












IC50 ≥ 500 μM for naringenin, 
rutin, hesperidin, resveratrol, 
and naringin
Quercetin efficiently 
inhibited cell population 
growth and increased 
induction of apoptosis
[36]





induced apoptosis, and 
reduced lipogenesis and 
proliferation, thereby 
contributing to reduce lipid 
accumulation. Reduced 
inflammatory response and 
improved insulin sensitivity
[37]
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Phytochemical(s) Methodology Beneficial effect(s) Reference
Ajoene Mature 3T3-L1 adipocytes
Ajoene at 200 μM decreased cell 
viability in 50% after 24 hours 
of treatment
Influenced the regulation of 
fat cell number
[38]
Green tea catechins 3 T3-L1 cells
Epigallocatechin or 
epigallocatechin gallate was 
added to the cell growing 
media in a dose from 1, 10, 
50, 100, 200, and 200 μM for 
some hours until some days 
(8–16 days)





Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vitro studies.
Phytochemical(s) Methodology Beneficial effect(s) Reference
Naringenin Rats and mice
10 mg/kg∙day by oral 
gavage for 4 weeks; 
0.1% in an experimental 
diet for 6 months; 1% 
and 3% in a high-fat 









50 mg/kg∙day by oral 
gavage for 4 weeks
Attenuated insulin resistance, 







acid, ursolic acid, 
α, β-amyrin, 
carbenoxolone, asiatic 





kg∙day, once daily, 
10 weeks) to fructose-
fed rats; ursolic acid-
treated fat-fed mice at a 
dose of 50 or 200 mg/kg 
of body weight (orally 
for 8 weeks); lupeol at 
0.67 g/kg, given orally 
for 7 weeks
Decreased fatty acid synthesis, 
triglyceride synthesis and plasma 
triglycerides, leptin and free fatty 
acids, and also triglyceride content 
in skeletal muscle
Reduced fatty liver, adipocyte size, 
hepatic steatosis, insulin resistance, 
inflammation, oxidative stress, 
body weight, atherosclerosis, and 
hypertension
Decreased cholesterol synthesis, 
total cholesterol, VLDL and LDL-




Carvacrol was added to 
the diet in a 0.1% (w/w) 
(equivalent to 100 mg/
kg body weight) for 
10 weeks
Prevented obesity by decreasing 
body weight gain, visceral fat-pad 
weights, and plasma lipid levels; 
also inhibited visceral adipogenesis 
and attenuated the production of 
pro-inflammatory cytokines in 
visceral adipose tissues
[41]




supplemented with 0.5% 
(w/w) oryzanol or 0.5% 
(w/w) ferulic acid for 
7 weeks
Decreased in body weight, 
improved blood glucose 
metabolism, may be beneficial 
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Phytochemical(s) Methodology Beneficial effect(s) Reference
Resveratrol A randomized, double-blind, placebo-
controlled clinical trial was carried out in 
24 patients with diagnosis of metabolic 
syndrome
12 patients received trans-resveratrol 
(500 mg) three times per day before 
meals for 90 days
Decreased weight, 
body mass index, 
fat mass, waist 
circumference, 









randomized clinical trial was carried 
out in 80 patients with a diagnosis of 
metabolic syndrome
80 patients with metabolic syndrome 
received 1800 mg of artichoke leaf 






Oligonol extract Randomized double-blind, placebo-
controlled study with 18 subjects.
All subjects took two capsules of Oligonol 






Pomegranate juice A randomized, double-blind, placebo-
controlled clinical trial was carried out 
in 20 obese [body mass index (BMI) 
30.0–39.9] adults
10 patients received 120 mL of 
pomegranate juice or placebo while in a 
fasted state before breakfast every day for 
1 month
Did not modify 
insulin secretion 
and sensitivity 
in patients with 
obesity; however, the 
natural evolution to 
increased weight and 
adiposity was halted
[47]
Phytochemical(s) Methodology Beneficial effect(s) Reference
Curcuminoids Rats
Rats were fed 
with high-fat diets 
with curcuminoid 
supplement at 
concentrations of 30, 60, 
and 90 mg per kilogram 
of body weight every day 
for 12 weeks
Decreased plasma free fatty 
acid levels and improves cardiac 
autonomic nervous system activity 
in obesity
Contributed to lower body fat and 
body weight gain
Improved obesity-associated 
inflammation and associated 
metabolic disorders such as 




Quercetin Rats and mice
Rats and mice fed with a 
Western diet containing 
0.05% quercetin for 
20 weeks
Decreased body weight, visceral 
fat, blood glucose, free cholesterol, 
total antioxidant status, lipid 
accumulation, and systolic blood 
pressure
[24]
Green tea catechins Rats and mice
Different dose-time 
treatment: from 0.5–4% 
of different catechins for 
6–22 weeks
Decreased body weight, total lipids, 
cholesterol, and triglycerides in 
liver and plasma. Also improved 
glucose homeostasis: increased 
glucose tolerance and decreased 
serum glucose, insulin resistance, 




Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vivo (preclinical trials) studies.
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In vitro studies achieve 50% of cell population growth inhibition with active 
compound amount of ppm, and, in some cases (some flavonoids, ajoene, cat-
echins), a dose-time-dependent effect is detected. These dose-time-dependent 
effects, together with the multivariate effects observed in most cases, are largely due 
to the antioxidant properties of the phytochemicals considered. Flavonoids tested 
on cell population growth were well correlated with their antioxidant activity [36].
The doses used in the preclinical studies were much higher than those used 
in the clinical trials, and the limitations in the ingested doses may be the cause of 
the ineffective results. Kobori et al. [24] concluded that in vitro anti-aggregatory 
effects of flavonoids are caused by concentrations that cannot be attained in vivo by 
dietary consumption.
In most preclinical studies, imbalances are induced in mice with a high fructose 
diet, and the effect that the active component has on these induced disorders is 
determined. Also in the clinical studies performed with positive results, the compo-
nent of interest was provided as part of a low-fat diet to patients with physiological 
alterations associated with metabolic syndrome. In these conditions the results show 
a palliative effect but in no case a preventive effect. Thus, quercetin supplementa-
tion did not affect the antioxidant status under healthy, normal conditions [24].
Sometimes solubility and bioavailability are a major limitation factor. As an 
example, pentacyclic triterpenes such as ursolic acid are poorly bioavailable because 
of poor aqueous solubility and permeability through biological membranes [26]. 
These limit their biological effects. Some strategies have increased bioavailability. 
For example, on comparing the oral bioavailability of ursolic acid microcrystals 
and nanocrystals to its coarse suspension in rats, ursolic acid microcrystals and 
nanocrystals exhibited 1.40- and 2.56-fold enhancement, respectively. Also, a new 
Phytochemical(s) Methodology Beneficial effect(s) Reference
Cocoa extract Double-blind, randomized, placebo-
controlled parallel nutritional 
intervention with 50 obese volunteers 
[30.59(2.33) kg/m2].
Meals supplemented with 1.4 g/day cocoa 
extract for 4 weeks
A marginal decrease 
(P = 0.072) in 
oxidized bases was 
observed, which 





Various randomized, double-blind, 
placebo-controlled clinical trials.
Some studies with different dose-time 
treatment: from 38 to 600 mg/day of 
different catechins for 6–24 weeks
Not all studies have 




has also shown no 
influence on body 
weight, body mass 
index, fat mass, 
and waist and hip 
circumference
[27]
Black seeds and 
turmeric
Double-blind randomized controlled trial
Black seeds (1.5 g/day), turmeric (2.4 g/
day), its combination (900 mg black 












Fruits, vegetables (or extracts), and phytochemicals endorsed by recent in vivo (clinical trials) studies.
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product from polyphenols of lychee has been developed. Oligonol, a unique low-
molecular-weight polyphenol, was developed to enhance absorption of polyphenols 
from the intestines. It contains 15.7% polyphenol monomer ((+)-catechin, (−)-epi-
catechin, etc.) and 13.3% polyphenol dimer (procyanidin B2, etc.), while lychee 
fruit-derived polyphenol contains 6.4% polyphenol monomer and 9.9% polyphenol 
dimer [46].
Concluding from above, translational studies from animal observations to 
human clinical trials and ultimately community interventions are needed to further 
confirm the effects of phytochemicals and foods rich in these bioactive compounds. 
The technological development should be aimed at the implementation of strategies 
that increase the bioavailability of active components with proven activity and that 
allow to provide the adequate doses avoiding toxicity problems.
2.2 Probiotics
Probiotics are defined as live microorganisms which, when administered in 
adequate amounts, confer a health benefit on the host [50]. Evidence from the latest 
studies in which probiotic efficiency in metabolic disorder management is assessed 
by both in vitro and in animal or human subjects is compiled in Tables 4 and 5.
Regarding the strains employed in the management of several inflammatory dis-
eases, they usually belong to the Lactobacillus and Bifidobacterium genera, although 
Pediococcus pentosaceus LP28, Bacteroides uniformis CECT 7771, and Akkermansia 
muciniphila have also been proved to have anti-obesity effects [65]. In general, doses 
Probiotic organism Methodology Beneficial effect(s) Reference
Lactobacillus 
plantarum Ln4 
isolated from napa 
cabbage kimchi
3T3-L1 adipocytes Inhibited adipogenesis 
and stimulated glucose 
uptake
[51]
Mice fed on a standard diet or 
a high-fat diet (5–7 mice per 
group) supplemented or not with 
5 × 108 CFU/day for 5 weeks
Reduced diet-induced 





10 rats fed on a normal diet and 
30 rats fed on a high-energy 
diet supplemented or not 




inflammation factors and 
increasing antioxidant 
enzymes in the serum
[52]









paracasei NTU 101 
originally isolated 
from infant
3T3-L1 pre-adipocyte model Fermented tea powder 
promoted lipase activity 
in adipocytes, which 
thereby improves the 
lipolytic effect
[53]
Rats fed for 8 weeks on a 
normal diet or a high-fat diet 
supplemented or not with:
• Unfermented tea powder
• (12.5 mg EGCG/day) Fermented 
tea powder
• (12.5–25 mg EGCG/day plus 
3.75–7 × 1010 CFU/day) NTU 101 
powder
• (7.5 × 1010 CFU/day)
• EGCG powder (25 mg/day)
NTU 101-fermented tea 
had a more significant 
effect on the reduction 
of body weight gain and 
body fat content than the 
unfermented tea
Nutraceuticals - Past, Present and Future
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greater than 108 CFU/day were orally administered to the drinking water or by oral 
gavage of the lyophilized bacterial powder in water (in animal studies) as well as 
in the form of capsules or fermented milk products (in human studies). Probiotic 
supplementation in rat and mouse studies usually applies to both diet-induced 
obese individuals and lean individuals fed on a high-fat diet, thus showing the 
effect of probiotics in both the treatment and the prevention of several metabolic 
abnormalities. However, human studies are basically applied to overweight or obese 
healthy individuals, submitted or not to energy restriction and/or regular exercise. 
As regards in vitro studies, treatment of 3T3-L1 pre-adipocytes with test substances 
during their differentiation stage is the most common technique.
Probiotic organism Methodology Beneficial effect(s) Reference
Lactobacillus 
fermentum strain 
4B1 isolated from 
fermented rice and 
shrimp compared to a 
commonly prescribed 
weight loss drug
35 obese induced mice. Daily dose: 
none, 12 mg/kg orlistat (Xenical®) 
or 2.5 × 1010 CFU/kg for 21 days
Prevented obesity in lean 
hosts and reduced body 
weight gain and adipose 
tissue weight in mice 
receiving the high-fat 
diet
[54]
Heat-killed and live 
Lactobacillus reuteri 
GMNL-263
Rats fed for 12 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 2 × 109 
cells/day for 12 weeks
Both heat-killed and live 
cells prevented obesity, 
insulin resistance, 
and hepatosteatosis 
in high-fat diet rats 
by suppressing the 
inflammatory response 
and the expressions of 
specific cytokines
[55]
Live or pasteurized 
Akkermansia 
muciniphila




capacity to reduce fat 
mass development, 
insulin resistance, and 







longum SPM 1205, 
and Bifidobacterium 
longum SPM 1207
36 rats fed for 5 weeks on a 
normal diet or a high-fat diet 
supplemented or not with 
108–109 CFU(1:1:1)/day
Reduced body weight 
and fat gain, as well 
as total cholesterol, 
HDL-cholesterol, and 
LDL-cholesterol levels 




ATCC PTA 4659, 
Lactobacillus reuteri 
DSM 17938, and 
Lactobacillus reuteri 
L6798
40 mice fed on a high-fat diet for 
12 weeks supplemented or not with 
109 CFU/day of a specific strain
Strain ATCC prevented 
obesity, lowered blood 
insulin level, and 
affected liver steatosis 
in hypercholesterolemic 




isolated from longan 
fruit and Lactobacillus 
plantarum SN13T
5 lean control and 30 diet-induced 
obese mice fed for 6 weeks 
with a regular diet or a high-fat 
diet supplemented or not with 
1.25 × 109 CFU/g of a specific strain
Live LP28 reduced body 
weight gain and liver 
lipid contents, whereas 




Probiotic strains endorsed by in vitro and animal studies.
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Probiotic organism Methodology Beneficial effect(s) Reference
DUOLAC 7 including 
S. thermophilus KCTC 
11870BP, L. plantarum 
KCTC 10782BP, L. 
acidophilus KCTC 
11906BP, L. rhamnosus 
KCTC 12202BP, B. 
lactis KCTC 11904BP B. 
longum KCTC 12200BP, 
and B. breve KCTC 
12201BP
(5 × 1012 CFU/capsule)
A randomized, double-blinded, 
placebo-controlled study in 
50 female aged 19–65 with 
BMI > 25 kg/m2 and waist 
circumference > 85 cm following 
usual dietary intake and lifestyle 
receiving Bofutsushosan (3 g per 
administration) and probiotics 
(1 capsule) or Bofutsushosan and 
placebo twice per day for 8 weeks
Probiotics increased 
HDL cholesterol 
level and effectively 
modified the 
composition of gut 
microbiota
Bifidobacterium 
breve was the only 
strain showing a 
significant tendency 
of declination of 
endotoxin level, so 
it was suggested as a 
promising probiotic 





in capsules (1.62 × 108 
CFU/capsule) with 
a mix 70:30, v/v of 
oligofructose and inulin 
(300 mg/capsule)
A double-blind, placebo-
controlled, randomized trial in 
125 healthy overweight men and 
women (age between 18 and 55, 
BMI between 29 and 41 kg/m2) 
following a supervised diet and 
consuming two capsules per day 
or placebo for 24 weeks
LPR supplementation 
accentuated 
body-weight loss in 
women submitted to 
energy restriction; 
this effect persisted 
in the subsequent 
maintenance 
phase, when energy 
restriction was not 
further imposed
[61]
L. plantarum TENSIA 
(DSM 21380) isolated 
from the gastrointestinal 
tract of healthy Estonian 
children added to cheese 
milk in amounts of 
1.5 × 1011 CFU/g before 
renneting
A randomized, double-blind, 
placebo-controlled, parallel-
designed study in 40 subjects with 
metabolic syndrome following a 
hypocaloric diet supplemented 
with 50 g/day of probiotic or 
control cheese for 3 weeks
The hypocaloric diet 
supplemented with 
the probiotic cheese 
reduced BMI, arterial 
blood pressure, 
and the risk of 
metabolic syndrome 
in obese patients with 
hypertension
[62]






trial in which 87 subjects (BMI of 
24.2–30.7 kg/m2 and abdominal 
visceral fat area of 81.2–178.5 cm2) 
were randomly assigned to 
consume 200 g/day of fermented 
milk with or without LG2055 for 
12 weeks while maintaining their 
habitual mode of living




fat areas as well 
as body weight, 











blind crossover clinical 
investigation with 28 healthy but 
overweight individuals (BMI 
between 25 and 32 kg/m2)
Probiotic consumption 
altered intestinal 
microflora in a manner 
that was associated 







Probiotic strains endorsed by in vivo studies.
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Among the analytical determinations, the most representative are changes in the 
body weight and the body fat content as well as main serum biochemical param-
eters (glucose, insulin, leptin, lipids, lipoproteins, and inflammatory indicators). 
Postmortem determinations, such as the liver weight or the adipose tissue histology, 
are also common in animal studies. Finally, since probiotics are known to increase 
the bacterial diversity of intestinal microflora, in vivo studies usually include viable 
counts in fecal samples and evaluation of intestinal survival. In fact, a lot of recent 
research relates gut microbiota composition with almost every chronic disease: from 
gastrointestinal diseases to obesity, diabetes, cancer, and even neurological and 
neurodegenerative disorders such as depression, autism, anxiety, and Parkinson’s 
disease [66]. Not only does a certain microbiota predispose to suffer certain dis-
eases, but also the incidence of a certain disorder modifies the gut microbiota of an 
individual. In overweight/obese subjects, Bacteroides, Parabacteroides, Ruminococcus, 
Campylobacter, Dialister, Porphyromonas, Staphylococcus, and Anaerostipes are 
the dominant genera linked to a low diversity of species, while Faecalibacterium, 
Bifidobacterium, Lactobacillus, Butyrivibrio, Alistipes, Akkermansia, Coprococcus, and 
Methanobrevibacter are predominant in lean individuals with a high bacterial diver-
sity [67]. Apparently, the intestinal microflora of obese subjects is more efficient 
at extracting energy from a given diet than that of lean individuals, thus leading 
to increased energy storage and adiposity [65]. Moreover, beneficial intestinal 
microflora is known to produce short-chain fatty acids (e.g., acetate, butyrate, and 
propionate) from indigestible polysaccharides, which may act as energy substrates 
as well as regulators of satiety and food intake. Last but not least, Lactobacilli and 
Bifidobacteria are known to synthesize bioactive isomers of conjugated linoleic 
acid with antidiabetic, anti-atherosclerotic, immunomodulatory, and anti-obesity 
properties [68]. In other words, low bacterial diversity in obese individuals is 
associated with a reduction in butyrate-producing bacteria, a reduction in hydrogen 
and methane production, an increase in mucus degradation, and an increase in 
the potential to manage oxidative stress. Since intestinal microflora composition is 
strongly affected by dietary patterns, studies evaluating the effect of certain food 
components on the growth of bacteria with beneficial effect on metabolic syndrome 
and obesity, particularly Akkermansia muciniphila and Faecalibacterium prausnitzii, 
are of great interest. Increasing the intestinal population of these two species has 
become a real opportunity to decrease alterations associated with obesity and meta-
bolic disorders [69]. In addition to this, high-fat diet treatment has been proven to 
induce metabolic changes that impair gut barrier function in rats [55].
Together with increasing gut microbiota diversity, the production by fermenta-
tive action of those bioactive molecules involved in the metabolic pathways that 
trigger the metabolic syndrome has also taken a lot of interest in the last years. In 
particular, many studies focus on the phenolic compound bioconversion by food fer-
mentation into other components with greater beneficial effect on the abnormalities 
associated with metabolic syndrome. As an example, Wang et al. [53] proved that 
the use of Lactobacillus paracasei subsp. paracasei strain NTU 101 in the fermentation 
of green tea and Houttuynia cordata leaves increased the levels of epigallocatechin 
gallate (EGCG), epigallocatechin (EGC), and chlorogenic acid, which enhanced the 
probiotic effect on body fat reduction. These results show the synergistic or comple-
mentary effect between the two bioactive compounds: the probiotic strain increases 
gut microbiota diversity and enhances intestinal absorption, while the EGCG acid 
promotes the lipolysis process. Zarrati et al. [70] also reported a synergistic effect 
between a weight loss diet and probiotic yogurt in overweight and obese individuals.
It should be noted that in order to exert their health benefits, probiotics do not 
necessarily have to be alive. In fact, heat-killed Lactobacillus reuteri GMNL 263 was 
as effective as live Lactobacillus reuteri GMNL 263 in attenuating obesity-induced 
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metabolic abnormalities in high-fat diet-induced rats by reducing insulin resistance 
and hepatic steatosis formation [55]. Also both heat-killed Lactobacillus planta-
rum strain Ln4 and freeze-dried cultured MRS broth significantly reduced lipid 
accumulation and stimulated glucose uptake in 3T3-L1 adipocytes [51]. Finally, 
Plovier et al. [56] found that pasteurization enhanced the capacity of Akkermansia 
muciniphila to reduce fat mass development, insulin resistance, and dyslipidemia 
in mice. It seems that a specific protein isolated from the outer membrane of 
Akkermansia muciniphila is stable at temperatures used for pasteurization and 
improves the gut barrier, thus being the main responsible factor of the beneficial 
effect of the bacteria on health.
Of all the studies analyzed, it is concluded that many microorganisms have 
the potential for development as therapeutic probiotics for obesity and associated 
disorders. However, due to the strain specificity of probiotic microbes in exerting 
their beneficial effects, bacterial strains of the same species have different effects on 
adiposity and insulin sensitivity.
3.  Case study: functional food development from lulo fruit with 
potential effect against metabolic syndrome
The lulo fruit (Solanum quitoense Lam.), also known as “naranjilla,” is an impor-
tant native Andean crop. Grown and consumed mainly in Colombia, Ecuador, 
and Central America, the plant produces a spherical, 3–8-cm-diameter fruit with 
orange skin (epicarp) covered by short, stiff, and thorny hairs or spines. The internal 
structure of the fruit is similar to that of the tomato fruit: a very juicy, acidic, and 
translucent yellow-green pulp (mesocarp and endocarp) that is located in four 
compartments separated by membranous partitions [71]. In Colombia, lulo is an 
economically important crop which, in 2015, was grown in a total area of 10,623 ha, 
with a total yield of 82,354 tons and an average yield of 9.6 tons/ha [72]. Although the 
principal market of this crop is in the producing countries themselves, it has gained 
interest in recent years in national and international markets due to its organoleptic 
properties and its nutritional value. In fact, lulo has an intense and refreshing taste 
and is rich in proteins, vitamin C, fiber, and antioxidant compounds, such as all-
trans-β-carotene, lutein and zeaxanthin, chlorogenic acids, and flavonol glycosides 
[73–76], in addition to iron, calcium, phosphorus, and some precursors of vitamin 
A [77] (Table 6 [78]). In particular, fruit carotenoids present in lulo fruit have been 
associated to the prevention of several illnesses, including hypertension, obesity, 
and cardiovascular diseases [79–81]. Also the potential of lulo as an antihypertensive 
agent is related to its content in N1,N4,N8-tris (dihydrocaffeoyl) spermidine and 
N1,N8-bis (dihydrocaffeoyl) spermidine (actually bioactive amines), which are 
bitter active compounds with inhibitory activity against the angiotensin-converting 
enzyme (ACE-1) that indirectly increases the blood pressure by causing blood vessels 
to constrict [35]. In turn, when evaluating the antihypertensive activity of some 
compounds of the lulo fruit by means of chemical computation techniques, the 
researchers of the Natural Additives of Aroma and Color group from the Chemistry 
Department of the Universidad Nacional de Colombia found that this was between 
10 and 20 times higher than that of the drugs traditionally used to treat hypertension.
Based on the considerations made above, the lulo fruit comes to be a promis-
ing alternative with regard to the prevention and relief of hypertension-related 
diseases. However, being a highly perishable fruit, technological transformation 
processes are indispensable to take advantage of its beneficial properties by as 
many consumers as possible. According to this, the group of Functional Foods of 
the University Institute of Food Engineering for Development of the Polytechnic 
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University of Valencia (Spain), in conjunction with the group of Biodiversity 
Evaluation and Use of the Technological University of Chocó (Colombia), is work-
ing on the development of new functional foods from lulo fruit (Solanum quitoense 
Lam). On the one hand, a stable lulo juice with improved antioxidant properties 
has been obtained by means of the application of moderate high homogenization 
pressures (from 50 to 150 MPa) instead of traditional thermal pasteurization. The 
same juice has proved to be a suitable impregnation liquid for the enrichment of 
other fruits with a porous structure, such as Granny Smith apples. The lulo fruit 
itself was found to have a high impregnation capacity, which implies susceptibility 
to be enriched with different bioactive compounds. Finally, after fermentation with 
Lactobacillus reuteri, selected for being one of the strains with proven effect against 
the metabolic syndrome, the number of viable counts in lulo juice resulted to be 
high enough to claim that it also may exert a probiotic effect. Most relevant results 
in relation to these advances are shown next.
3.1  Enhancing antioxidant properties of lulo juice by means of moderate  
high-pressure homogenization
This section shows the effect that homogenization pressures in the range of 
50–150 MPa have on main physicochemical properties, including the total content 
of phenols and flavonoids and the antioxidant activity measured by both DPPH and 
ABTS methods. To obtain the juice, washed and without peduncle lulo fruits were 
crushed for 10 min in a blender (Phillips Avance Collection Standmixer, 800W 2L). 
The liquefied product was then filtered with a stainless steel sieve of 500 μm nomi-
nal aperture. When necessary, the juice was homogenized at 50, 100 or 150 MPa in 
a laboratory scale high-pressure homogenizer (Panda Plus 2000, GEA-Niro Soavi, 
Parma, Italy).
Proximates Minerals Vitamins
Carb 5.9 g Ca 8 mg Folate 3 μg
Fiber 1.1 g Mg 11 mg Vit B3 1.45 mg
Protein 0.44 g P 12 mg Vit B5 0.22 mg
Sugars 3.74 g K 200 mg Vit B1 0.05 mg
Fat 0.22 g Na 4 mg Vit B6 0.11 mg
Water 93.05 g Cu 0.03 mg Vit C 3.2 mg
Energy 25 cal Fe 0.35 mg α-Carotene 4 μm
Mn 0.07 mg β-Carotene 333 μm
Se 0.4 μg β-Cryptoxanthin 10 μm







Values expressed for 100 g of fresh fruit.
Table 6. 
Nutrition facts of lulo fruit.
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As it can be observed in Table 7, neither the soluble solid content nor the pH 
or the density of the lulo juices was significantly affected by homogenization 
pressure. On the contrary, the consistency index (K) increased significantly after 
the homogenization step, which is directly related to particle size reduction. As 
regards the average size of particles, it was maximum in the non-homogenized juice 
(251 ± 5 μm) and minimum in the juice homogenized at 150 MPa (57.94 ± 0.14 μm). 
Therefore, homogenization increased the amount of solids in suspension and, 
consequently, the stability of the cloud.
As regards the antioxidant properties of lulo juice, the fruit’s own transforma-
tion into juice significantly reduced both total phenol and total flavonoid contents, 
which were probably separated from the juice together with the bagasse during the 
filtration step. However, the concentration of such compounds increased slightly 
(from 1.03 ± 0.16 to 1.28 ± 0.07 mg GAE/g for phenols and from 0.35 ± 0.24 to 
0.570 ± 0.011 mg QE/g for flavonoids) after juice homogenization at 150 MPa 
and the subsequent reduction in the average particle size. Similar trends were 
observed when analyzing the total antioxidant activity by both the ABTS and the 
DPPH methods and when quantifying spermidine by HPLC analysis. For the latter 
compound, concentration increased from 1.86 ppm in non-homogenized lulo juice 
to 2.04 ppm in lulo juice homogenized at 150 MPa.
Regarding the ability of the homogenized lulo juice treated at 150 MPa to 
impregnate Granny Smith apples sliced, it was found to be similar to that of an 
isotonic sucrose solution. In this way, the bioactive compounds present in lulo juice 
may become part of the vacuum impregnated fruit composition. To be more pre-
cise, around 0.22 m3 of lulo juice homogenized at 150 MPa could be incorporated to 
every m3 of fresh apple.
3.2 Lulo fruit as a food matrix for vacuum impregnation and food property 
improvement
In this section, impregnation properties of lulo fruit are discussed. Vacuum 
impregnation being a matrix engineering technique allows to introduce desirable 
compounds into the porous structure of foods by applying a pressure gradient [14]. 
Among the impregnation parameters, the volume of the external liquid that can be 
incorporated into the cellular tissue in a controlled way (i.e., X, in m3/m3) stands 
out, which informs about the feasibility of incorporating physiologically active com-
pounds into its porous structure for the formulation of new products with enhanced 
functional properties. Hence, unpeeled lulo fruit was cut into 5 mm thick slices and 
immersed in an isotonic sucrose solution (aw = 0.994 ± 0.003). Vacuum impreg-
nation was carried out in a pilot plant scale equipment located at the University 
Institute of Food Engineering for Development of the Universitat Politècnica de 
Homogenization 
pressure
Brix pH ρ (g/cm3) K (Pa sn) n
0 MPa 6.57 ± 0.12a 3.13 ± 0.02a 1.04 ± 0.02a 0.39 ± 0.12a 0.44 ± 0.06b
50 MPa 6.4 ± 0.4a 3.12 ± 0.02a 1.06 ± 0.04a 0.9 ± 0.4b 0.37 ± 0.04a
100 MPa 6.33 ± 0.15a 3.18 ± 0.03a 1.07 ± 0.02a 0.79 ± 0.02ab 0.37 ± 0.03a
150 MPa 6.4 ± 0.4a 3.15 ± 0.02a 1.09 ± 0.02a 1.3 ± 0.5b 0.34 ± 0.04a
abc… different superscripts in the same column indicate statistically significant differences (p < 0.05).
Table 7. 
Effect of homogenization pressure on pH, soluble solid content (brix), apparent density (ρ), and rheological 
properties of lulo juice.
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València (Spain). This equipment consists of a stainless steel vacuum chamber con-
nected to a liquid ring pump (SIHI model LOHE-25007). The vessel containing the 
impregnating solution was placed into the vacuum chamber, and the lulo samples 
were immersed in the liquid by means of a pneumatic arm operated by a compressor 
(COMBA, 1,5 HP de 25 L). The working conditions were set at 50 mbar for 10 min 
and atmospheric pressure for 10 min more. In each trial, the weight change of the 
samples was recorded according to the procedure described by [82], thus allowing 
to calculate the characteristic impregnation parameters of the lulo fruit.
As it is shown in Table 8, the different batches analyzed behaved in a similar way 
during the vacuum impregnation step. Positive values of parameters X1 (between 
1 and 5%) and X (between 8.6 and 16%) indicate that the impregnating liquid 
entered the porous structure after both the vacuum and the atmospheric steps. 
Likewise, positive values of parameters γ1 (between 3.9 and 7.1%) and γ (between 
2.9 and 6.6%) indicate a volumetric expansion of the lulo matrix after both the 
vacuum and the atmospheric steps. Compared to other fruits and vegetables [83], 
the volume fraction of fresh lulo that was filled with the impregnating solution 
at the end of the process (X, in m3/100 m3) was significantly lower than that of 
Granny Smith apple (21.0 ± 0.9) or Soraya aubergine (64 ± 2) but considerably 
higher than that of Chandler strawberry (6.4 ± 0.3), Hayward kiwifruit (0.7 ± 0.5), 
or Bulida apricot (2.2 ± 0.2). Despite such differences, the lulo matrix can be 
considered as suitable to be enriched with other active compounds by means of the 
vacuum impregnation technique.
3.3 Probiotic food development from lulo fruit
The growing number of consumers with lactose intolerance, high cholesterol 
levels, and/or following vegetarian or vegan diets has encouraged the recent use of 
fruits and vegetables as probiotic carriers in the development of new functional 
foods. Fruit and vegetable juices are especially suitable for the growing of probiotic 
microorganisms since they inherently contain beneficial nutrients and have taste 
profiles that are pleasing to all the age groups [84]. In addition, due to their fast 
passage through the digestive tract, the viability of probiotic cells in the juices is 
hardly affected by the harsh acidic environment of stomach [85]. However, these 
food matrices do not always fulfill the pH or the essential amino acids and vitamins 
required for the optimum growth of most LAB with proven probiotic effect. This 
section evaluates the possibility of using the non-homogenized lulo juice as a 
medium for the growth of Lactobacillus reuteri CECT 925T. For this purpose, the 
lulo juice obtained by the procedure described above was pasteurized at 75°C for 
Batch X1 γ1 X γ εe
1 5 ± 7a 5 ± 4a 8.8 ± 1.6a 3 ± 3a 6 ± 4a
2 2.1 ± 1.8a 6 ± 5a 10 ± 3a 5 ± 4a 6 ± 5a
3 2 ± 4a 5 ± 2a 11 ± 2ab 3.7 ± 0.9a 8 ± 2a
4 1 ± 1.4a 3.9 ± 0.9a 16 ± 6b 6.6 ± 1.0a 9 ± 6a
5 2.5 ± 1.3a 7.1 ± 1.0a 8.6 ± 0.9a 2.9 ± 0.8a 6.3 ± 1.2a
abc… different superscripts in the same column indicate statistically significant differences (p ≤ 0.05).
X1 and X stand for the volume fraction of fresh sample impregnated at the end of the vacuum step and at the end of 
the atmospheric step, respectively; γ1 and γ stand for the relative volume deformation of fresh sample at the end of the 
vacuum step and at the end of the atmospheric step, respectively; εe stands for the effective porosity.
Table 8. 
Vacuum impregnation response of lulo fruit slices (5 mm thick).
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2.5 min before being inoculated with 4 mL/L of MRS broth containing the active 
microorganism in a concentration of 108 CFU/mL. After 24 hours of incubation 
at 37°C, viable counts in the juice were of the order of 106 CFU/mL. Although this 
value was high enough to make an EU-based health claim [86], it was significantly 
lower to that obtained in mandarin juice inoculated with either Lactobacillus 
salivarius spp. salivarius CECT 4063 or Lactobacillus acidophilus CECT 903 [87].
In a further step, the lulo juice containing the probiotic was employed as impreg-
nating liquid for the vacuum impregnation of Granny Smith apple slices (5 mm 
thick). In this way, the probiotic was introduced into a solid matrix without disturb-
ing its organized cellular structure. However, since only 20% of the initial volume 
of the apple is filled with the impregnation liquid during the vacuum impregnation 
step, the probiotic content in the impregnated apple was not greater than 105 CFU/g. 
Subsequent lyophilisation of the vacuum impregnated apples did not increase the 
Lactobacillus reuteri content as expected by water removal and subsequent weight 
loss, it being lower than 106 CFU/g in the liophylized sample. Probiotic counts in 
both the lulo juice and the impregnated apple snack could be improved by adding 
certain ingredients (e.g., prebiotics, cryprotectants, soygerm powder, yeast extract, 
etc.) and/or applying specific processing technologies that can improve microorgan-
ism survival such as microencapsulation or sublethal homogenization. In any case, 
it should be interesting to evaluate through both in vivo and in vitro studies the anti-
hypertensive activity of Lactobacillus reuteri in the products designed, since it could 
be enhanced due to a synergistic effect with the spermidine from the lulo juice.
4. Market and consumer trends toward functional foods
Revolution in living standard, eating habits, and increased health awareness has 
shifted consumer’s acceptance toward nutritious, healthy, and disease-preventive food 
with wider health benefits. Consumer is becoming more and more conscious about 
the role of food in life extension, well-being, and prevention of chronic diseases [87].
Specific consumer characteristics, such as demographic background or personal 
motivation to participate in pro-health activities, play a remarkable role in func-
tional food acceptance and consumption. Some sociodemographic characteristics 
such as gender, education, and age are the most important factors related to the 
acceptance of functional food. In addition, apart from health benefits, the carrier 
and the origin of functional components play an important role in making the 
decision to purchase functional products, consumers being more likely to purchase 
those functional components found naturally in foods. Other factors, such as 
organoleptic attributes, convenience, or label information, are found to be essential 
for consumer’s acceptance. In his study, Kraus [88] concludes that consumers are 
not willing to sacrifice taste and general pleasure of eating and also states that 
naturalness of a product is very important.
Particularly for probiotics, a major challenge for these products is product 
acceptability by consumers with regard to sensory criteria. Traditionally, health 
benefits of probiotics were based in the consumption of fermented dairy products; 
however, lactose intolerance, cholesterol content, and allergic milk proteins have 
limited the growth of dairy probiotics. Besides, the increase in vegetarian consum-
ers in both developed and developing countries has also contributed to a growing 
demand for plant-based probiotic products [87]. According to Panghal et al. [89], 
fruits are healthy and refreshing and have good taste and flavor profile and can 
be suitable for probiotics. They are an ideal medium to develop functional foods 
and have more nutritional values due to the presence of various phytochemicals, 
antioxidants, no cholesterol, vitamins, mineral content, and dietary fibers. Besides, 
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economic reasons for the developing countries also require the search for an alter-
native to dairy products with good nutrients along with health-promoting factors, 
e.g., fruits, vegetables, cereal, legume, etc., and products which lack cholesterol 
content but are rich in protein, starches, minerals, fiber, vitamins, and antioxidants.
Nowadays an increasing trend in the Western society is consumer interest and 
focus toward natural and organic products, where the use of synthetic additives is 
limited. It has been suggested that natural ingredients with strong antioxidant activity 
could be used to design novel functional beverages. An increased interest relies upon 
the fortification with polyphenols due to their beneficial role against cardiovascular 
diseases, type 2 diabetes, and obesity, among other conditions. The combination of 
prebiotics, and also phenols with probiotic microorganisms, represents an innovative 
biotechnology to enlarge the functional food market and especially beverages [90].
According to Grand View Research [91], the global functional food market was 
higher than 129 billion dollars (US) in 2015, and it is expected to increase up to 250 
billion in 2024. Growing consciousness among consumers on their health and proper 
diet, together with the prospect of reducing or even eliminating nutrition-related 
diseases, is responsible of this market trend. Society is becoming more and more con-
scious on the impact that changing dietary patterns may have in the incidence of type 
2 diabetes, coronary heart disease, cancer, periodontal disease, and obesity. In this 
regard, functional foods are believed to play an outstanding role. In addition, increas-
ing healthcare cost, along with the desire of improving later years among the geriatric 
population, has driven the growth of the functional food industry worldwide.
The global functional food market includes that of carotenoids, dietary fibers, 
fatty acids, minerals, prebiotics and probiotics, vitamins, minerals, phytochemicals, 
enzymes, and antioxidants in general. Market revenue of all these products sepa-
rately is also expected to increase in the coming years. For example, dietary fibers, 
which are considered to prevent obesity and diabetes, are expected to grow by 8.4% 
in the next 8 years. Other phytochemicals, such as flavonoids, held a share of over 
30% in terms of market value. Although these have been commonly consumed in 
their natural form, consumer’s habits have led to their use in the form of functional 
food products which are aimed at preventing diet-related chronic diseases including 
those related to the metabolic syndrome. North America accounts for the largest 
market in flavonoids, the Asia Pacific demand was over 110 million US Dollars 
in 2015, and Europe is expected to grow, although at a slower pace. In any case, 
prevalence of diabetes, obesity, and chronic diseases is likely to propel demand for 
these nutritional foods and beverages in Europe.
With regard to probiotics, there is also a growing concern on awareness in their 
functional health benefits against different conditions, including those related to 
the metabolic syndrome such as obesity or type 2 diabetes [92]. The global probiotic 
market was thought to be worth 35.5 billion dollars in 2016, with predictions of this 
increasing up to 65 billion dollars by 2024 [93]. As reported by Lumina intelligence 
[92], a survey of Ganeden on consumers concluded that almost 80% of consumers 
preferred to consume probiotics in food and beverage products than in supple-
ments. This is of special value taking into account that consumer preference is a 
key currency for measuring product success and predicting upcoming tendencies. 
North America demand for probiotics is expected to increase by 7.9% from 2016 to 
2025, whereas the European market will grow at a pace of 7.3%. As for Asia Pacific 
countries, the probiotics industry is also expected to increase significantly.
Probiotics have achieved a prominent position in the global food market. Among 
the countries that have shown growth in the probiotic market, Europe represents the 
largest and fastest growing market, followed by Japan. Currently, there is a wide range 
of probiotic products offered by companies such as BioGaia Biologics AB, Christian 
Hansen A/S, ConAgra Functional Foods, Danisco, Groupe Danone, or Lifeway [87].
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5. Conclusions
The huge increase in obesity and consequently of physiological disorders associ-
ated with this has led to a massive increase in research work conducted in this area 
over the past 10 years. The relationship between diet and the incidence of metabolic 
syndrome is clearly contrasted. Although this relationship is tremendously complex 
and it is hardly affected by other variables related to lifestyle, specific works estab-
lish phytochemicals and probiotics as two of the active components present in food, 
which have the greatest effect on prevention and in the reduction of symptoms 
associated with metabolic syndrome.
Currently, the technological development achieved by the food industry allows 
both the design and development of specific foods that include active components in 
their composition as well as the application of specific techniques that increase the 
functional value of natural foods. The use of these advances in the right direction 
can be decisive in the solution of health problems related to obesity. Specifically, the 
applications of moderate homogenization pressures or food formulation techniques, 
such as vacuum impregnation, are presented as possibilities to develop liquid and/
or solid foods that combine the presence of phytochemicals and probiotics with 
demonstrated effectiveness against obesity in natural foods such as lulo fruit.
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